出版社:American Society for Biochemistry and Molecular Biology
摘要:Group IIA secretory phospholipase A2 (sPLA2) is an acute-phaseprotein mediating decreased plasma HDL cholesterol and increasedatherosclerosis. This study investigated the impact of macrophage-specificsPLA2 overexpression on lipoprotein metabolism and atherogenesis.Macrophages from sPLA2 transgenic mice have 2.5 times increasedrates of LDL oxidation (thiobarbituric acid-reactive substancesformation) in vitro (59 ± 5 vs. 24 ± 4 nmol malondialdehyde/mgprotein; P < 0.001) dependent on functional 12/15-lipoxygenase(12/15-LO). Low density lipoprotein receptor-deficient (LDLR–/–)mice were transplanted with bone marrow from either sPLA2 transgenicmice (sPLA2 LDLR–/–; n = 19) or wild-type C57BL/6littermates (C57 BL/6LDLR–/–; n = 19) and maintainedfor 8 weeks on chow and then for 9 weeks on a Western-type diet.Plasma sPLA2 activity and plasma lipoprotein profiles were notsignificantly different between sPLA2LDLR–/– andC57BL/6LDLR–/– mice. Aortic root atherosclerosiswas increased by 57% in sPLA2LDLR–/– mice comparedwith C57BL/6LDLR–/– controls (P < 0.05). Foamcell formation in vitro and in vivo was increased significantly.Urinary, plasma, and aortic levels of the isoprostane 8,12-iso-iPF2-VIand aortic levels of 12/15-LO reaction products were each significantlyhigher (P < 0.001) in sPLA2LDLR–/– compared withC57BL/6LDLR–/– mice, indicating significantly increasedin vivo oxidative stress in sPLA2 LDLR–/–.
These data demonstrate that macrophage-specific overexpressionof human sPLA2 increases atherogenesis by directly modulatingfoam cell formation and in vivo oxidative stress without anyeffect on systemic sPLA2 activity and lipoprotein metabolism.Supplementary key words secretory phospholipase A2 • lipoxygenase • hypercholesterolemia • inflammation • lipoproteins